Skip to main content

LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2025

Written by Customer Service on . Posted in Public Companies.

Lannion, March 21, 2025– 5:45pm

LUMIBIRD: ACCESS TO PREPARATORY DOCUMENTS
FOR THE COMBINED GENERAL MEETING ON APRIL 29, 2025

LUMIBIRD’s shareholders are informed that they are invited to take part in the Combined General Meeting to be held on Tuesday, April 29th, 2025 from 2:00pm (CET) at 15 rue du Zéphyr, ZA de Courtabœuf, 91140 VILLEJUST- France.

The meeting notice containing the agenda, the text of the resolutions and the main conditions for taking part in and voting at the General Meeting was published in the French official gazette (Bulletin des Annonces Légales Obligatoires, BALO) on March 19, 2025 (Bulletin no.34/ Notice no. 2500690).

It can be downloaded from LUMIBIRD’s website at www.lumibird.com and the BALO site at balo.journal-officiel.gouv.fr.

Shareholders are invited to vote by post or email or by proxy using the dedicated voting form, available on the Company’s website (www.lumibird.com), or online with the secure voting platform VOTACCESS.

In accordance with the law, all the documents to be provided for this General Meeting will be made available to shareholders under the conditions and within the regulatory timeframes applicable, on LUMIBIRD’s website www.lumibird.com, under “Regulated Information / Proxy material for AGMs”, and at LUMIBIRD’s registered office at 2, rue Paul Sabatier, 22300 Lannion, France.

These documents will also be able to be sent out to shareholders following a simple request submitted to:

UPTEVIA
Service Assemblées Générales
Ms Nadia Goul
90 – 110 Esplanade du Général de Gaulle
92931 Paris La Défense Cedex

and/or:

LUMIBIRD
Ms Aude Nomblot-Gourhand
Financial Director
Tel: +33 (0)1 69 29 17 00
info@lumibird.com

Next: publication Q1 2025 sales on 28/04/2025, after close of trading

LUMIBIRD is one of the world’s leading laser specialists. With over 50 years’ experience and expertise in solid-state, diode and fibre laser technologies, the Group designs, manufactures and distributes high-performance laser solutions via two divisions: Photonics and Medical. The Photonics Division designs and produces components, lasers and systems for the defence and space, environment, topography and security, industrial and scientific, and medtech markets. The Medical branch designs and produces medical diagnostic and treatment systems for ophthalmology.
The result of the October 2017 merger between the Keopsys and Quantel Groups, LUMIBIRD, with more than 1,000 employees and €207.1m in sales in 2024, is present in Europe, America and Asia.
LUMIBIRD shares are listed in compartment B of Euronext Paris. FR0000038242 – LBIRD        www.lumibird.com
LUMIBIRD has been a member of Euronext since 2022.Tech Leaders

Contacts

LUMIBIRD
Marc Le Flohic
Chairman and Chief Executive Officer
Tel. +33(0) 1 69 29 17 00
info@lumibird.com		LUMIBIRD
Sonia Rutnam
Chief Financial and Transformation Officer
Tel. +33(0) 1 69 29 17 00
info@lumibird.com		Calyptus
Mathieu Calleux
Investor Relations
Tel. +33(0) 1 53 65 37 91
lumibird@actus.fr

Attachment

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.